retail-banking.ru


Vor Biopharma Stock

Track Vor Biopharma Inc (VOR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Vor Biopharma Inc. (retail-banking.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Vor Biopharma Inc. | Nasdaq: VOR. Is Vor Biopharma Inc. stock A Buy? Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may.

The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to. View the real-time VOR price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Loading chart ; About Vor Biopharma Inc. Common Stock (VOR). Loading info ; Key Statistics. Loading info ; News. Loading info.

Shield the healthy cells, expose the cancer - Vor Bio (also known as Vor Biopharma) aims to cure blood cancers through cell and genome engineering. VOR | Complete Vor Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Discover real-time Vor Biopharma Inc. Common Stock (VOR) stock prices, quotes, historical data, news, and Insights for informed trading and investment.

View Vor Biopharma, Inc. VOR stock quote prices, financial information, real-time forecasts, and company news from CNN.Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution.Get Vor Biopharma Inc (VOR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

The latest Vor Biopharma stock prices, stock quotes, news, and VOR history to help you invest and trade smarter. Get the latest Vor Biopharma Inc. (VOR) stock news and headlines to help you in your trading and investing decisions. Vor Biopharma has % upside potential, based on the analysts' average price target. Vor Biopharma has a consensus rating of Strong Buy which is based on. VOR Stock Overview · Revenue is forecast to grow % per year · Has less than 1 year of cash runway · Makes less than USD$1m in revenue ($0) · Currently.

The stock price for Vor Biopharma (NASDAQ: VOR) is $ last updated August 9, at PM EDT. Q. Does Vor Biopharma (VOR). PROFILE (VOR). Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel. View the VOR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vor Biopharma Inc real. VOR's current price target is $ Learn why top analysts are making this stock forecast for Vor Biopharma at MarketBeat. Mult.) Upgrade. Profile Drag and drop to reorder or search profile items. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel.

Stock Price Forecast. The 6 analysts with month price forecasts for Vor Biopharma stock have an average target of , with a low estimate of and a. (NASDAQ: VOR) Vor Biopharma currently has 68,, outstanding shares. With Vor Biopharma stock trading at $ per share, the total value of Vor Biopharma. Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely? (Simply Wall St.) Oct AM · Vor Bio. VOR - Vor Biopharma Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS).


Copyright 2018-2024 Privice Policy Contacts